Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cantabio Pharmaceuticals

Cantabio Pharmaceuticals
2009 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
CTBO STOCK SYMBOL
1 INVESTMENTS
$25.00 SHARE PRICE (As of Thursday Closing)
Description

Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.

Formerly Known As
Gardedam Therapeutics
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
PINX
Primary Office
  • 2225 East Bayshore Road
  • Palo Alto, CA 94303
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cantabio Pharmaceuticals’s full profile, request a free trial.

Cantabio Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$10.50 - $244.00 $564K $25.00 -$200.00 60.41 22.5K

Cantabio Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
FY 2016
31-Mar-2016
Enterprise Value 2,316 3,324 4,189 53,610
Revenue 0 0 0 0
EBITDA (331) (1,392) (1,072) (751)
Net Income (1,543) (2,012) (1,112) (751)
Total Assets 326 109 34 52
Total Debt 1,409 1,205 369 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cantabio Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cantabio Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Cantabio Pharmaceuticals Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alector Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
000000000 Formerly VC-backed South San Francisco, CA 00 00000 000000000 00000
0000000 Venture Capital-Backed Framingham, MA 0 0000 0000000000 0 0000
0000000 00000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
0000000 Venture Capital-Backed Singapore, Singapore 00 00000 0000000000 0 00000
To view this company’s complete list of competitors, request access »

Cantabio Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0000000000 00 18-Dec-2015 000000000000000000 Consulting Services (B2B) 0000000 0ó00 00.0
To view this company’s complete investment and acquisition history, request access »

Cantabio Pharmaceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
Gergely Tóth Ph.D Founder & Chief Executive Officer
Thomas Roger Sawyer Ph.D Chief Operating Officer
Simon Peace Chief Accounting Officer